References
- Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE Prevention Study Group. JAMA 1995; 274(1): 29–34
- Hunt LW, Rosenow EC 3d. Asthma- producing drugs. Ann Allergy 1992; 68(6): 453–62
- Dahlen B, Kumiin M, Margolskee DJ, et al. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J 1993; 6(7): 1018–26
- Sweet JM, Stevenson DD, Simon RA, et al. Long-term effects of aspirin desensitization: treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990; 85(1 Pt 1): 59–65
- Settipane RA, Schrank PJ, Simon RA, et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995; 96(4): 480–5
- Szczeklik A, Nizankowska E, Dworski R. Choline magnesium trisalicylate in patients with aspirin-induced asthma. Eur Respir J 1990; 3(5): 535–9
- Stevenson DD, Hougham AJ, Schrank PJ, et al. Salsalate cross-sensitivity in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 1990; 86(5): 749–58
- Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984;74(4 Pt 2): 617–22
- Lin RY. A perspective on penicillin allergy. Arch Intern Med 1992; 152(5): 930–7
- Dykewicz MS. Drug allergy. Compr Ther 1996; 22(6): 353–9
- Saxon A, Adelman DC, Patel A, et al. Imipenem cross-reactivity with penicillin in humans. J Allergy Clin Immunol 1988; 82(2): 213–7
- Fernandez-Rivas M, Perez Carral C, Cuevas M, et al. Selective allergic reactions to clavulanic acid. J Allergy Clin Immunol 1995; 95(3): 748–50
- Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995; 74(2): 167–70
- Kalanadhabhatta V, Muppidi D, Sahni H, et al. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome. Ann Allergy Asthma Immunol 1996; 77(5): 394–400 '
- Patterson R. Allergic diseases. Philadelphia: Lippincott, 1993: 494–7
- Sullivan TJ. Cross-reactions among furosemide, hydrochlorothiazide, and sulfonamides. JAMA 1991; 265(1): 120–1
- Lunde H, Hedner T, Samuelsson O, et al. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1994; 308(6920): 18–21
- Kaufman J, Schmitt S, Barnard J, et al. Angiotensin-Converting enzyme inhibitors in patients with bronchial responsiveness and asthma. Chest 1992; 101(4): 922–5
- Hargreaves MR, Benson MK. Inhaled sodium cromoglycate in angiotensin- converting enzyme inhibitor cough. Lancet 1995; 345(8941): 13–6
- Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988; 260(7): 967–70
- Losartan for hypertension. Med Lett Drugs Ther 1995; 37(951): 57–8
- Lang DM, Alpern MB, Visintainer PF, et al. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med 1993; 153(17): 2033–40
- Lasser EC, Berry CC, Talner LB, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med 1987; 317(14): 845–9
- Greenberger PA, Halwig JM, Patterson R, et al. Emergency administration of radiocontrast media in high-risk patients. J Allergy Clin Immunol 1986;77(4): 630–4
- Greenberger PA, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 1991; 87(4): 867–72